Rinat Neuroscience Corporation

Rinat is a biopharmaceutical company whose mission is to discover, develop and commercialize protein therapeutics for diseases and disorders of the nervous system. The company was founded in 2001 as a spin-out from Genentech. Rinat currently has over 75 employees, two-thirds of whom are in research and development. Rinat is in a strong position to address the significant unmet medical needs in the neurology market. The company is focused on developing disease modifying therapies in areas of significant medical need. Specifically, Rinat has active research and/or clinical programs.

Contact Details: 230 E. Grand Avenue South San Francisco California 94080 United States of America Tel: (650) 615-7300 Fax: (650) 615-7350 Email: info@rinatneuro.com WWW: www.rinatneuro.com/

Loading...

Recent Publications by Rinat Neuroscience Corporation:
Regulatory issues in aging pharmacology. Many current drugs increase the average lifespan by preventing fatal...	19th April, 2006	Rinat Neuroscience Corporation, South San Francisco, California 94080,	Aging Cell. 2006 Feb;5(1):3-8. DOI Direct Link
Novel class of pain drugs based on antagonism of NGF. Nerve growth factor (NGF) was identified originally as a survival factor...	6th April, 2006	Rinat Neuroscience Corporation, 230 East Grand Avenue, South San	Trends Pharmacol Sci. 2006 Feb;27(2):85-91. Epub 2005 Dec 27. DOI Direct Link
Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain and cachexia are two of the most debilitating aspects of rheumatoid...	1st September, 2005	Rinat Neuroscience Corp., 3155 Porter Drive, Palo Alto, CA 94304, USA.	Pain. 2005 Jul;116(1-2):8-16. DOI Direct Link
Molecular basis for catecholaminergic neuron diversity. Catecholaminergic neurons control diverse cognitive, motor, and endocrine...	16th December, 2004	Rinat Neuroscience, 3155 Porter Drive, Palo Alto, CA 94304, USA.	Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13891-6. Epub 2004 Sep 7. DOI Direct Link
Molecular mechanisms controlling the development of dopaminergic neurons. Dopaminergic (DA) neurons in the midbrain are critically involved in...	27th February, 2004	Rinat Neuroscience	Semin Cell Dev Biol. 2003 Jun;14(3):175-80.
→View more Rinat Neuroscience Corporation research publications.

Rinat Neuroscience Corporation Patents:
US Patent No.	Title
7425329	Methods for treating bone cancer pain by administering a nerve growth factor antagonist
7255860	Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody
7252822	Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 461 times since April 2007, the link to the organisation's website has been followed 77 times

Search for more companies in South San Francisco

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Rinat Neuroscience Corporation